RT Conference Proceedings
T1 Risk factors in pediatric T-cell acute lymphoblastic leukemia: a collaborative study of the biological committee of the leukemia group of the Spanish Hematology and Oncology Pediatric Society
A1 Vega-García, N
A1 Torrebadell, M
A1 Jiménez-Velasco, A
A1 Ortega, M
A1 Abad, L
A1 Pratcorona, M
A1 Muñoz, L
A1 Malatesta, R
A1 Calvente, L
A1 Català, A
A1 Berrueco, R
A1 Ruiz-Llobet, A
A1 Estella, C
A1 Trabazo, M
A1 Alonso-Saladrigues, A
A1 Mesegué, M
A1 Pascual, A
A1 Lassaletta, Á
A1 Badell, I
A1 Pisa, S
A1 Velasco, MR
A1 Dapena, JL
A1 Rives, S
A1 Ramirez-Orellana, M
A1 Camós, M
K1 Biomarcadores
K1 Proteínas del ciclo celular
K1 Niño
K1 Proteínas F-box
K1 Humanos
K1 Mutación
K1 Leucemia-linfoma linfoblástico de células T precursoras
K1 Ubicuitina-proteína ligasas
AB Background: Useful biomarkers for risk stratification in pediatric T-ALL arestill needed. Several biological variables have been proposed as new prognosticbiomarkers, including NOTCH1, FBXW7, PTEN & RAS mutations,expression of myeloid antigens and presence of copy number alterations(CNAs) of certain genes, but published results are controversial.Aims: To analyze the prognostic impact of mutations, CNAs and myeloid antigensexpression in a series of 56 pediatric T-ALL patients.
PB Ferrata Storti Foundation
SN 0390-6078
YR 2016
FD 2016-06
LK http://hdl.handle.net/10668/2435
UL http://hdl.handle.net/10668/2435
LA en
NO Vega-García N, Torrebadell M, Jiménez-Velasco A; Ortega M, Abad L, Pratcorona M, et al. Risk factors in pediatric T-cell acute lymphoblastic leukemia: a collaborative study of the biological committee of the leukemia group of the Spanish Hematology and Oncology Pediatric Society. Haematologica. 2016; 101 (s1) E870.
DS RISalud
RD Apr 11, 2025